Fig. 2From: Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016–2017 epidemic season: a systematic review of seven Italian reportsa. Length of stay, in days, for infants with and without chronic disease, b. Length of stay in days for premature infants versus not prematureBack to article page